Products and Services

When it comes to cancer, "maybe" is not an answer

At the forefront of cancer management are State of the Art genomic diagnostics and precision oncology, taking into account patient's varibility in genes, enviroment and lifestyle.

Global incidence of cancer is of epidemic proportions, one out of two men and one out of three women will get cancer in their lifetime. In Pakistan, annually 90,000 women are diagnosed and 40,000 die of breast cancer. MammaPrint + BluePrint test is recommended to help make breast cancer treatment decisions.

In 2000, entire human DNA was sequenced and today Next Generation Sequencing (NGS) DNA technology captures a broad spectrum of mutations in the tumor of cancer patient for diagnosis, prognosis and treatment. Our xT 648 and OncoPlus, NGS universal genomic panels are now available for cancer patients in Pakistan.